Recombinant fusion protein expression of Indonesian isolate Newcastle disease virus in Escherichia coli BL21(DE3)

##plugins.themes.bootstrap3.article.main##

MARTHA PURNAMI WULANJATI
https://orcid.org/0000-0002-2478-6963
LUCIA DHIANTIKA WITASARI
https://orcid.org/0000-0001-9614-4540
NASTITI WIJAYANTI
https://orcid.org/0000-0001-6483-2816
ARIS HARYANTO
https://orcid.org/0000-0001-8477-764X

Abstract

Abstract. Wulanjati MP, Witasari LD, Wijayanti N, Haryanto A. 2021. Recombinant fusion protein expression of Indonesian isolate Newcastle disease virus in Escherichia coli BL21(DE3). Biodiversitas 22: 3249-3255. Newcastle disease is a major problem in poultry industry due to high mortality of susceptible chicken. New vaccine agents are important to be developed to eliminate the disease threat. This study aimed to examine the expression of fusion (F) protein of Newcastle Disease Virus (NDV) from Indonesian isolates in E. coli BL21(DE3) by IPTG induction. The sample was a part of F gene of NDV from Galur, Kulon Progo, Yogyakarta, Indonesia (0663/04/2013) with a molecular size of 600 bp that was synthesized and inserted into pBT7-N-His expression vector. The recombinant F protein with molecular weight of 25.6 kDa was successfully expressed in E. coli BL21(DE3), purified using Ni-NTA magnetic silica beads, and confirmed by western blotting. Optimization of expression showed that recombinant F protein was optimally expressed by induction of 1.0 mM IPTG when the cells reached OD600 = 0.6. The induction duration was 8 h. B-cell epitopes prediction showed that F protein possessed four epitopes that possibly recognized by B-cell. Since recombinant F protein was considered to possess immunogenicity, its potency as a candidate of NDV vaccine agent should be investigated in the future.

##plugins.themes.bootstrap3.article.details##

References
Astuti RW, Wijayanti N, Haryanto A. 2020. Expression of recombinant fusion protein from local isolate of Newcastle Disease Virus and antibody response to recombinant fusion protein in broiler chicken post-vaccination. J. Indo. Trop. Anim. Agri. 45(2): 78-90. DOI: 10.14710/jitaa.45.2.78-90
Cardenas-Garcia S, Diel DG, Susta L, Lucio-Decanini E, Yu Q, Brown CC, Miller PJ, Afonso CL. 2015. Development of an improved vaccine evaluation protocol to compare the efficacy of Newcastle disease vaccines. Biologicals 43(2): 136–145. DOI: 10.1016/j.biologicals.2014.11.003
de Marco A, Ferrer-Miralles N, Garcia-Fruitos E, Mitraki A, Peternel S, Rinas U, Trujillo-Roldan MA, Valdez-Cruz NA, Vazquez E, Villaverde A. 2019. Bacterial inclusion bodies are industrially exploitable amyloids. FEMS Microbiology Reviews 43(1): 53–72. DOI: 10.1093/femsre/fuy038
Dimitrov KM, Abolnik C, Afonso CL, Albina E, Bahl J, Berg M, et al. 2019. Updated unified phylogenetic classification system and revised nomenclature for Newcastle disease virus. Infect. Genet. Evol. 74:103917. DOI: 10.1016/j.meegid.2019.103917
Dimitrov KM, Afonso CL, Yu Q, Miller PJ. 2017. Newcastle disease vaccines—A solved problem or a continuous challenge? Vet. Microbiol. 206: 126–136. DOI: 10.1016/j.vetmic.2016.12.019
Etriwati, Ratih D, Handharyani E, Setiyaningsih S. 2017. Pathology and immunohistochemistry study of Newcastle disease field case in chicken in Indonesia. Vet. World 10(9): 1066–1071. DOI: 10.14202/vetworld.2017.1066-1071
Firouzamandi M, Moeini H, Hosseini D, Bejo MH, Omar AR, Mehrbod P, Ideris A. 2016. Improved immunogenicity of Newcastle disease virus inactivated vaccine following DNA vaccination using Newcastle disease virus hemagglutinin-neuraminidase and fusion protein genes. J Vet Sci. 17(1): 21-6. DOI: 10.4142/jvs.2016.17.1.21
Haryanto A, Wati V, Pakpahan S, Wijayanti N. 2016. Molecular pathotyping of Newcastle disease virus from naturally infected chickens by RT-PCR and RFLP methods. A. J. Anim. Sci. 10(1): 39-48. DOI: 10.3923/ajas.2016.39.48
Haryanto A, Wihadmadyatami H, Wijayanti N. 2020. In vitro expression of the recombinant fusion protein of Newcastle disease virus from local Indonesian isolates by using a cell-free protein expression system. I. J. Biotech. 25(2): 69-75. DOI: 10.22146/ijbiotech.54703
Hasan A, Hossain M, Alam J. 2013. A computational assay to design an epitope-based peptide vaccine against Saint Louis Encephalitis virus. Bioinform. Biol. Insights 7: 347–355. DOI: 10.4137/BBI.S13402
Izquierdo-Lara R, Chumbe A, Calderón K, Fernández-Díaz M, Vakharia VN. 2019. Genotype-matched Newcastle disease virus vaccine confers improved protection against genotype XII challenge: The importance of cytoplasmic tails in viral replication and vaccine design. PLoS One 14(11): e0209539. DOI: 10.1371/journal.pone.0209539
Jazayeri SD, Poh CL. 2019. Development of universal influenza vaccines targeting conserved viral proteins. Vaccines 7(4): 169. DOI: 10.3390/vaccines7040169
Jonasson P, Liljeqvist S, Nygren PA, Ståhl S. 2002. Genetic design for facilitated production and recovery of recombinant proteins in Escherichia coli. Biotechnol. Appl. Biochem. 35(2): 91–105. DOI: 10.1042/ba20010099
Kang X, Wang J, Jiao Y, Tang P, Song L, Xiong D, Yin Y, Pan Z, Jiao X. 2016. Expression of recombinant Newcastle disease virus F protein in Pichia pastoris and its immunogenicity using flagellin as the adjuvant. Protein Expr. Purif. 128: 73–80. DOI: 10.1016/j.pep.2016.08.009
Kaur J, Kumar A, Kaur J. 2018. Strategies for optimization of heterologous protein expression in E. coli: Roadblocks and reinforcements. Int. J. Biol. Macromol. 106: 803-822. DOI: 10.1016/j.ijbiomac.2017.08.080
Larentis AL, Nicolau JFMQ, Esteves GS, Vareschini DT, de Almeida FVR, Reis MG, Galler R, Medeiros MA. 2014. Evaluation of pre-induction temperature, cell growth at induction and IPTG concentration on the expression of a leptospiral protein in E. coli using shaking flasks and microbioreactor. BMC Res. Notes. 7(1): 671. DOI: 10.1186/1756-0500-7-671
Mariappan AK, Munusamy P, Kumar D, Latheef SK, Singh SD, Singh R, Dhama K. 2018. Pathological and molecular investigation of velogenic viscerotropic Newcastle disease outbreak in a vaccinated chicken flocks. Virusdisease. 29(2):180-191. DOI: 10.1007/s13337-018-0445-5
Murwantoko, Fusianto CK, Triyanto. 2016. Gene Cloning and Protein Expression of Koi Herpesvirus ORF25. Hayati J. Biosci. 23(3): 143-149. DOI: 10.1016/j.hjb.2016.10.001
Putri CN, Haryanto A. 2019. Fusion recombinant protein expression of Newcastle disease virus from Escherichia coli-Cloned C1a using accurapid TM protein expression kit. IOP Conf. Ser. Earth Environ. Sci. 355: 012026.
Putri DD, Handharyani E, Soejoedono RD, Setiyono A, Mayasari NLPI, Poetri ON. 2017. Pathotypic characterization of Newcastle disease virus isolated from vaccinated chicken in West Java, Indonesia. Vet. World 10(4): 438–444. DOI: 10.14202/vetworld.2017.438-444
Shofa M, Wibawan IWT, Zarkasie K, Setiyaningsih S. 2018. Molecular analysis of Newcastle disease virus isolated from a vaccinated layer farm in Indonesia. IOP Conf. Ser. Earth Environ. Sci. 197(1): 012044.
Singhvi P, Saneja A, Srichandan S, Panda AK. 2020. Bacterial Inclusion Bodies: A Treasure Trove of Bioactive Proteins. Trends Biotechnol. 38(5): 474-486. DOI: 10.1016/j.tibtech.2019.12.011
Trimpin S, Brizzard B. 2018. Analysis of insoluble proteins. BioTechniques 46(6): 409-419. DOI: 10.2144/000113135
Wang Y, Bi Y, Yu W, Wei N, Wang W, Wei Q, Wang X, Zhang S, Yang Z, Xiao S. 2017. Two mutations in the HR2 region of Newcastle disease virus fusion protein with a cleavage motif “RRQRRL” are critical for fusogenic activity. Virol. J. 14(1): 185. DOI: 10.1186/s12985-017-0851-0
Wulanjati MP, Wijayanti N, Haryanto A. 2018. Phylogenetic analysis of Newcastle disease virus from Indonesian isolates based on DNA-sequence of fusion protein-encoding gene. Biotechnol. 17(2): 69–74. DOI: 10.3923/biotech.2018.69.74
Xiao S, Paldurai A, Nayak B, Samuel A, Bharoto EE, Prajitno TY, Collins PL, Samal SK. 2012. Complete genome sequences of Newcastle disease virus strains circulating in chicken populations of Indonesia. J. Virol. 86(10): 5969–5970. DOI: 10.1128/JVI.00546-12

Most read articles by the same author(s)